Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VACC

Vaccitech (VACC) Stock Price, News & Analysis

Vaccitech logo

About Vaccitech Stock (NASDAQ:VACC)

Key Stats

Today's Range
$1.51
$1.58
50-Day Range
$1.19
$5.00
52-Week Range
$1.64
$5.10
Volume
74,197 shs
Average Volume
244,643 shs
Market Capitalization
$58.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VACC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccitech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VACC Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.tc pixel
BRNS Stock Earnings: Barinthus Biotherapeutics Misses EPS for Q2 2024
See More Headlines

VACC Stock Analysis - Frequently Asked Questions

Vaccitech plc (NASDAQ:VACC) issued its quarterly earnings data on Friday, November, 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.38) by $0.25. The firm earned $0.02 million during the quarter, compared to the consensus estimate of $1.65 million. Vaccitech had a negative trailing twelve-month return on equity of 23.41% and a negative net margin of 409.18%.

Vaccitech (VACC) raised $110 million in an IPO on Friday, April 30th 2021. The company issued 6,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Jefferies, Barclays and William Blair acted as the underwriters for the IPO and H.C. Wainwright & Co., LLC was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccitech investors own include Intel (INTC), Johnson & Johnson (JNJ), Snap (SNAP), TJX Companies (TJX), Walt Disney (DIS), NIO (NIO) and Okta (OKTA).

Company Calendar

Last Earnings
11/12/2021
Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VACC
CIK
1828185
Fax
N/A
Employees
33
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
($1.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$5.34 million
Net Margins
-409.18%
Pretax Margin
-442.00%
Return on Equity
-23.41%
Return on Assets
-20.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
15.26
Quick Ratio
15.26

Sales & Book Value

Annual Sales
$13.42 million
Price / Sales
4.34
Cash Flow
$0.08 per share
Price / Cash Flow
19.30
Book Value
$6.52 per share
Price / Book
0.23

Miscellaneous

Outstanding Shares
38,547,000
Free Float
36,234,000
Market Cap
$58.21 million
Optionable
Not Optionable
Beta
-0.40

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:VACC) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners